glutathion synthase ligase Glutamate cysteine and the age-related decline in cellular glutathione: The therapeutic potential of γ-glutamylcysteine Stimulation of de novo glutathione

Provide institutional review committees with COAs and handling documentation as needed

The treatment, which was previously indicated only for symptomatic children 3 years of age and older with late infantile CLN2 disease, also known as Batten disease, can now be given to diagnosed children of all ages, regardless of whether they are symptomatic or presymptomatic

Li Y, Ye T, Yang F, Hu M, Liang L, He H, Li Z, Zeng A, Li Y, Yao Y, Xie Y, An Z, Li S (2016) Punica granatum (pomegranate) peel extract exerts potent antitumor and anti-metastasis activity in thyroid cancer

Upcoming FDA Decisions fo r January 2026 Tividenofusp alfa (BLA), January 5 Denali Therapeutics For the treatment of Hunter syndrome

It doesnt get out of your gut